These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24995710)

  • 1. Maxitrol-induced corneal melts after routine cataract surgery in rheumatology patients.
    Lockington D; Sharma R; Mantry S; Ramaesh K
    Clin Exp Ophthalmol; 2015 Mar; 43(2):188-9. PubMed ID: 24995710
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe corneal melting after cataract surgery in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy.
    Cabourne E; Lau N; Flanagan D; Nott J; Bloom J; Angunawela R
    J Cataract Refract Surg; 2020 Jan; 46(1):138-142. PubMed ID: 32050243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal perforation in undiagnosed Sjögren's syndrome following topical NSAID and steroid drops post routine cataract extraction.
    Murtagh P; Comer R; Fahy G
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30042108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery.
    van Endt JJ; Veraart HG; Kramer R; Janssen AG; Sunder Raj P
    Eur J Ophthalmol; 1997; 7(2):144-8. PubMed ID: 9243217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
    Shulman DG; Sargent JB; Stewart RH; Mester U
    Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAXITROL SUSPENSION AND OINTMENT: CLINICAL EVALUATION OF TWO NEW ANTIBIOTIC-STEROID PREPARATIONS.
    MAXWELL E; AIJIAN KM
    Curr Ther Res Clin Exp; 1964 Feb; 6():130-3. PubMed ID: 14135297
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome.
    Ansari H; Weinberg L; Spencer N
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24038291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 1-day versus 1-hour application of topical neomycin/polymyxin-B before cataract surgery.
    Li B; Miño de Kaspar H; Haritoglou C; Kook D; Kampik A; Sheng M; Nentwich MM
    J Cataract Refract Surg; 2015 Apr; 41(4):724-31. PubMed ID: 25840297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punctal stenosis in 6 dogs following the long-term use of topical neomycin-polymyxin B-dexamethasone.
    Quantz K; Stiles J
    Vet Ophthalmol; 2019 Mar; 22(2):196-200. PubMed ID: 30211477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of local application of isoptomax eye drops on neuromuscular transmission].
    Koenig A; Ohrloff C
    Klin Monbl Augenheilkd; 1981 Aug; 179(2):109-12. PubMed ID: 6290749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced corneal sensitivity in patients with primary Sjögren's syndrome.
    Han SB; Hyon JY; Wee WR; Lee JH; Lee YJ; Yun PY
    Acta Ophthalmol; 2010 Nov; 88(7):e277-8. PubMed ID: 19860768
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse cutaneous hypersensitivity reaction after dexamethasone/polymyxin B/neomycin combination eyedrops.
    Baldinger J; Weiter JJ
    Ann Ophthalmol; 1986 Mar; 18(3):95-6. PubMed ID: 3008629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spontaneous corneal perforation in rheumatoid polyarthritis. Presentation of 2 cases].
    Saraux H; Laroche L; Orcel L; Josset P
    Bull Soc Ophtalmol Fr; 1984 Feb; 84(2):159-62. PubMed ID: 6529839
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in intraocular pressure within 1 week of phacoemulsification and intraocular lens implantation using Adatocel.
    Biro Z; Balogh T
    J Cataract Refract Surg; 2006 Apr; 32(4):573-6. PubMed ID: 16698474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new cohesive ophthalmic viscosurgical device on corneal protection and intraocular pressure in small-incision cataract surgery.
    Neumayer T; Prinz A; Findl O
    J Cataract Refract Surg; 2008 Aug; 34(8):1362-6. PubMed ID: 18655988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren's syndrome. A dry-eyed diary.
    Tarail J
    Am J Nurs; 1987 Mar; 87(3):324-6. PubMed ID: 3644597
    [No Abstract]   [Full Text] [Related]  

  • 18. Corneal blindness from end-stage Sjögren's syndrome and graft-versus-host disease.
    Dohlman CH; Dudenhoefer EJ; Khan BF; Dohlman JG
    Adv Exp Med Biol; 2002; 506(Pt B):1335-8. PubMed ID: 12614075
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect on corneal endothelial cell loss during phacoemulsification: fortified balanced salt solution versus Ringer lactate.
    Nayak BK; Shukla RO
    J Cataract Refract Surg; 2012 Sep; 38(9):1552-8. PubMed ID: 22832531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femtosecond laser-assisted cataract surgery without OVD: a prospective intraindividual comparison.
    Schargus M; Suckert N; Schultz T; Kakkassery V; Dick HB
    J Refract Surg; 2015 Mar; 31(3):146-52. PubMed ID: 25751829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.